Sign in
CompletedNo phase

Endoscopic Classification of Fundoplication Integrity Predicts Pathologic Reflux

Key facts

Who runs it
IRCCS Policlinico S. Donato
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
153 people enrolled
Started
1 Apr 2018
Ended
1 Jul 2026
Type of study
Observational, 3 groups
Record updated
27 July 2026

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Adults (18-90 years)
  • Previous Nissen or Toupet fundoplication for GERD or large hiatal hernia
  • Completion of post-operative esophagogastroduodenoscopy (EGD)
  • Adequate retroflexed endoscopic videoclip
  • Post-operative High-resolution manometry (HRM) and reflux monitoring (MII-pH or wireless pH)

Who cannot take part

  • Other foregut operations (Dor, Collis, magnetic sphincter augmentation, bariatric surgery)
  • Insufficient quality of endoscopic videoclips
  • Missing HRM or reflux monitoring

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This single-center, two-phase cohort study aimed to develop and validate a simple endoscopic classification of fundoplication integrity after anti-reflux surgery (ARS - Nissen or Toupet fundoplication). Consecutive adult patients undergoing endoscopy, high-resolution manometry (HRM), and reflux monitoring after ARS were included. Retroflexed endoscopic videoclips were reviewed blinded to clinical and functional results. In the development cohort (2018-2024, n=73), individual endoscopic parameters were tested against pathologic GERD (Lyon 2.0 criteria). Three parameters significantly correlated with pathologic reflux: (1) intrathoracic valve location, (2) disrupted valve (deep anterior and/or posterior grooves), and (3) visible hiatal opening. Patients were stratified according to the number of impaired mechanisms (0-3). Symptom burden, manometric abnormalities, and reflux metrics worsened progressively with increasing impairment. The rate of pathologic GERD rose from 11.8% (0 mechanisms) to 37.5% (1-2 mechanisms) to 85.7% (3 mechanisms). The classification was then prospectively validated in an independent cohort (2024-2026, n=49), reproducing the same stepwise correlation. The number of impaired mechanisms showed excellent discriminatory capacity for pathologic GERD (AUC 0.860 in development, 0.870 in validation; overall AUC 0.869). This simple endoscopic classification, based on only three objective parameters, reliably identifies fundoplication failure and correlates with symptoms and objective pathophysiologic data. It has the potential to standardize endoscopic reporting after ARS.

The 3 groups in the trial

  • Normal fundoplication

    Patients with 0 impaired mechanisms of ARB restoration

  • Partially impaired fundoplication

    Patients with 1-2 impaired mechanisms of ARB restoration

  • Fully impaired fundoplication

    Patients with 3 impaired mechanisms of ARB restoration

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
ENDOSCOPIC CLASSIFICATION OF FUNDOPLICATION INTEGRITY PREDICTS PATHOLOGIC REFLUX: DEVELOPMENT AND PROSPECTIVE VALIDATION
Record updated
27 July 2026